Informationen:
Fehler:
ID
18794
Beschreibung
Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa; ODM derived from: https://clinicaltrials.gov/show/NCT00381472
Link
https://clinicaltrials.gov/show/NCT00381472
Stichworte
Versionen (1)
- 21.11.16 21.11.16 -
Hochgeladen am
21. November 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Parkinson Disease NCT00381472
Eligibility Parkinson Disease NCT00381472
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Parkinson Disease NCT00381472
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Parkinson Disease
Item
idiopathic parkinson's disease
boolean
C0030567 (UMLS CUI [1])
UPDRS - Modified Hoehn and Yahr Staging
Item
modified hoehn and yahr scale stages ii - iv
boolean
C3639878 (UMLS CUI [1])
Levodopa Dose Stable
Item
stable dose of l-dopa for at least 4 weeks prior to screening.
boolean
C0023570 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Levodopa | control Lack
Item
lack of control with l-dopa therapy.
boolean
C0023570 (UMLS CUI [1])
C0243148 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C0243148 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods
Item
women of child-bearing potential must use a clinically accepted form of birth control.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
Medical condition Significant | Medical condition Uncontrolled | Parkinson Disease
Item
significant and/or uncontrolled medical conditions (excluding parkinson's disease) within 3 months of screening.
boolean
C3843040 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0030567 (UMLS CUI [3])
C0750502 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0030567 (UMLS CUI [3])
Abnormality Relevant Clinical
Item
any abnormality, at screening, that is considered clinically relevant by the investigator.
boolean
C1704258 (UMLS CUI [1,1])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Dementia
Item
dementia
boolean
C0497327 (UMLS CUI [1])
Dopamine Agonists
Item
use of dopamine agonists within 4 weeks of screening visit.
boolean
C0178601 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs
Item
participation in other investigational drug studies.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])